Abstract
Multiple efforts to model the epidemiology of SARS-CoV-2 have recently been launched in support of public health response at the national, state, and county levels. While the pandemic is global, the dynamics of this infectious disease varies with geography, local policies, and local variations in demographics. An underlying assumption of most infectious disease compartment modeling is that of a well mixed population at the resolution of the areas being modeled. The implicit need to model at fine spatial resolution is impeded by the quality of ground truth data for fine scale administrative subdivisions. To understand the trade-offs and benefits of such modeling as a function of scale, we compare the predictive performance of a SARS-CoV-2 modeling at the county, county cluster, and state level for the entire United States. Our results demonstrate that accurate prediction at the county level requires hyper-local modeling with county resolution. State level modeling does not accurately predict community spread in smaller sub-regions because state populations are not well mixed, resulting in large prediction errors. As an important use case, leveraging high resolution modeling with public health data and admissions data from Hillsborough County Florida, we performed weekly forecasts of both hospital admission and ICU bed demand for the county. The repeated forecasts between March and August 2020 were used to develop accurate resource allocation plans for Tampa General Hospital.
2010 MSC 92-D30, 91-C20
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding sources for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No PII data. All data on hospital and ICU admissions are publicly available.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data is available through USA Facts. TGH data is available at link below.
https://usafacts.org/visualizations/coronavirus-covid-19-spread-map